Stemcell Tecnologies

Stemcell Technologies is a Canadian biotechnology company headquartered in Vancouver, British Columbia, specializing in the development and distribution of cell culture media, cell separation systems, and advanced biological research products. As a foreign-owned, for-profit enterprise, the company has established a significant presence in the U.S. federal market, particularly within biomedical research agencies. Through its U.S. subsidiary, Stemcell Technologies Inc., the company has secured multiple federal contract awards, primarily from various National Institutes of Health (NIH) institutes and other health-related federal agencies.

The company's federal contract awards demonstrate a robust portfolio of specialized biological materials and scientific equipment supporting critical research initiatives. Stemcell Technologies has consistently provided products such as cell isolation kits, cell culture media, reagents, and maintenance services for specialized scientific instruments like RoboSep-S cell separators. Their contracts span multiple federal agencies including the National Institute on Aging, National Heart Lung and Blood Institute, NIH Clinical Center, Centers for Disease Control and Prevention, National Institute of Mental Health, National Institute on Drug Abuse, Department of Veterans Affairs, and Defense Health Agency. The contract awards, ranging from $10,000 to $162,655, are predominantly firm fixed-price purchase orders and are not set aside for small businesses. The company holds a substantial $10 million Blanket Purchase Agreement with the NIH, facilitating streamlined procurement of research materials across various institutes and supporting research in areas such as infectious diseases, immunology, stem cell research, cancer studies, and translational medicine.